Cargando…

Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.

Viable cultured oat-cell carcinoma cells were used to immunize a goat. The resulting antiserum contained high titres of anti-normal activity and antibodies to CEA. It was also shown, by indirect immunofluorescence, using fluorescein-conjugated rabbit anti-goat Ig, to localize at high titres on the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, C. E., Ford, C. H., Parkes, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1978
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009627/
https://www.ncbi.nlm.nih.gov/pubmed/207297
_version_ 1782136153242075136
author Newman, C. E.
Ford, C. H.
Parkes, E.
author_facet Newman, C. E.
Ford, C. H.
Parkes, E.
author_sort Newman, C. E.
collection PubMed
description Viable cultured oat-cell carcinoma cells were used to immunize a goat. The resulting antiserum contained high titres of anti-normal activity and antibodies to CEA. It was also shown, by indirect immunofluorescence, using fluorescein-conjugated rabbit anti-goat Ig, to localize at high titres on the surface membranes of human lung cancer cells of 4 different histological types. Booster immunizations produced a maximum secondary response one week after 2 weekly injections. The course of each immunization has been monitored for activity against normal human tissues, and the final sera have been absorbed with human spleen cells to remove anti-normal activity. Cross-reactivity with the lung-cancer-cell panel and antibodies to CEA persisted in high titre after absorption of anti-normal antibodies, and were present in the ammonium-sulphate-precipitated globulin fraction. The cells used for immunization did not produce detectable amounts of CEA in culture, and were not known to contain CEA prior to this experiment. Removal of anti-CEA antibodies by absorption with purified CEA has not reduced the cross-reactivity of the absorbed antiserum with the panel of human lung-cancer cells.
format Text
id pubmed-2009627
institution National Center for Biotechnology Information
language English
publishDate 1978
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20096272009-09-10 Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells. Newman, C. E. Ford, C. H. Parkes, E. Br J Cancer Research Article Viable cultured oat-cell carcinoma cells were used to immunize a goat. The resulting antiserum contained high titres of anti-normal activity and antibodies to CEA. It was also shown, by indirect immunofluorescence, using fluorescein-conjugated rabbit anti-goat Ig, to localize at high titres on the surface membranes of human lung cancer cells of 4 different histological types. Booster immunizations produced a maximum secondary response one week after 2 weekly injections. The course of each immunization has been monitored for activity against normal human tissues, and the final sera have been absorbed with human spleen cells to remove anti-normal activity. Cross-reactivity with the lung-cancer-cell panel and antibodies to CEA persisted in high titre after absorption of anti-normal antibodies, and were present in the ammonium-sulphate-precipitated globulin fraction. The cells used for immunization did not produce detectable amounts of CEA in culture, and were not known to contain CEA prior to this experiment. Removal of anti-CEA antibodies by absorption with purified CEA has not reduced the cross-reactivity of the absorbed antiserum with the panel of human lung-cancer cells. Nature Publishing Group 1978-05 /pmc/articles/PMC2009627/ /pubmed/207297 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Newman, C. E.
Ford, C. H.
Parkes, E.
Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
title Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
title_full Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
title_fullStr Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
title_full_unstemmed Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
title_short Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
title_sort preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009627/
https://www.ncbi.nlm.nih.gov/pubmed/207297
work_keys_str_mv AT newmance preparationandcharacterizationofanantiserumtoculturedhumanoatcellcarcinomacells
AT fordch preparationandcharacterizationofanantiserumtoculturedhumanoatcellcarcinomacells
AT parkese preparationandcharacterizationofanantiserumtoculturedhumanoatcellcarcinomacells